153 related articles for article (PubMed ID: 32681429)
1. Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer.
Maksymchuk OV; Kashuba VI
Pharmacol Rep; 2020 Oct; 72(5):1161-1172. PubMed ID: 32681429
[TBL] [Abstract][Full Text] [Related]
2. The roles of cytochrome P450 enzymes in prostate cancer development and treatment.
Chen TC; Sakaki T; Yamamoto K; Kittaka A
Anticancer Res; 2012 Jan; 32(1):291-8. PubMed ID: 22213318
[TBL] [Abstract][Full Text] [Related]
3. [Recent studies on vitamin D metabolizing enzymes].
Sakaki T
Clin Calcium; 2006 Jul; 16(7):1129-35. PubMed ID: 16816472
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor agonist EB1089 is a potent regulator of prostatic "intracrine" metabolism.
Doherty D; Dvorkin SA; Rodriguez EP; Thompson PD
Prostate; 2014 Feb; 74(3):273-85. PubMed ID: 24242708
[TBL] [Abstract][Full Text] [Related]
5. Enzymes involved in the activation and inactivation of vitamin D.
Prosser DE; Jones G
Trends Biochem Sci; 2004 Dec; 29(12):664-73. PubMed ID: 15544953
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D in Prostate Cancer.
Ahn J; Park S; Zuniga B; Bera A; Song CS; Chatterjee B
Vitam Horm; 2016; 100():321-55. PubMed ID: 26827958
[TBL] [Abstract][Full Text] [Related]
7. Expression of vitamin D-metabolizing enzymes in human adipose tissue -- the effect of obesity and diet-induced weight loss.
Wamberg L; Christiansen T; Paulsen SK; Fisker S; Rask P; Rejnmark L; Richelsen B; Pedersen SB
Int J Obes (Lond); 2013 May; 37(5):651-7. PubMed ID: 22828938
[TBL] [Abstract][Full Text] [Related]
8. Cytochromes P450 are essential players in the vitamin D signaling system.
Schuster I
Biochim Biophys Acta; 2011 Jan; 1814(1):186-99. PubMed ID: 20619365
[TBL] [Abstract][Full Text] [Related]
9. Characterization of androgen-regulated expression of CYP3A5 in human prostate.
Moilanen AM; Hakkola J; Vaarala MH; Kauppila S; Hirvikoski P; Vuoristo JT; Edwards RJ; Paavonen TK
Carcinogenesis; 2007 May; 28(5):916-21. PubMed ID: 17116727
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of vitamin D3 by cytochromes P450.
Sakaki T; Kagawa N; Yamamoto K; Inouye K
Front Biosci; 2005 Jan; 10():119-34. PubMed ID: 15574355
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract.
Blomberg Jensen M; Nielsen JE; Jørgensen A; Rajpert-De Meyts E; Kristensen DM; Jørgensen N; Skakkebaek NE; Juul A; Leffers H
Hum Reprod; 2010 May; 25(5):1303-11. PubMed ID: 20172873
[TBL] [Abstract][Full Text] [Related]
13. Associations between abnormal vitamin D metabolism pathway function and non-small cell lung cancer.
Ge N; Chu XM; Xuan YP; Ren DQ; Wang Y; Ma K; Gao HJ; Jiao WJ
Oncol Lett; 2017 Dec; 14(6):7538-7544. PubMed ID: 29250167
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 Vitamin D Hydroxylases in Inflammation and Cancer.
Gröschel C; Tennakoon S; Kállay E
Adv Pharmacol; 2015; 74():413-58. PubMed ID: 26233913
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral Sterol-27-Hydroxylase (
Khan NA; Stopsack KH; Allott EH; Gerke T; Giovannucci EL; Mucci LA; Kantoff PW
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1052-1058. PubMed ID: 30867220
[TBL] [Abstract][Full Text] [Related]
16. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3.
Kägi L; Bettoni C; Pastor-Arroyo EM; Schnitzbauer U; Hernando N; Wagner CA
PLoS One; 2018; 13(5):e0195427. PubMed ID: 29771914
[TBL] [Abstract][Full Text] [Related]
17. In Silico Prediction of the Metabolic Resistance of Vitamin D Analogs against CYP3A4 Metabolizing Enzyme.
Żołek T; Yasuda K; Brown G; Sakaki T; Kutner A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887195
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and prostate cancer.
Tuohimaa P; Lyakhovich A; Aksenov N; Pennanen P; Syvälä H; Lou YR; Ahonen M; Hasan T; Pasanen P; Bläuer M; Manninen T; Miettinen S; Vilja P; Ylikomi T
J Steroid Biochem Mol Biol; 2001; 76(1-5):125-34. PubMed ID: 11384870
[TBL] [Abstract][Full Text] [Related]
19. Genetic Expression Profile of Vitamin D Metabolizing Enzymes in the First Trimester.
Ekström L; Storbjörk L; Björkhem-Bergman L
Horm Metab Res; 2016 Dec; 48(12):834-839. PubMed ID: 27813049
[TBL] [Abstract][Full Text] [Related]
20. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
Vis AN; Schröder FH
BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
